IP Library Assignment 035604/0484
Patent Assignment
Reel/Frame 035604/0484

Assignment of Assignor's Interest

Recorded: 2015-05-11 Pages: 10
Assignor
NOVARTIS AG
Executed: 2015-04-20
Assignee
ARROWHEAD RESEARCH CORPORATION
225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101
Covered Properties (13)
RNAi inhibition of serum amyloid a for treatment of glaucoma
Application: 11/313,210 →
Publication: US 2006/0172961
RNAi-mediated inhibition of ocular hypertension targets
Application: 11/344,702 →
Publication: US 2006/0172963
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Patent: 7,947,660 →
Application: 11/373,376 →
Publication: US 2006/0223773
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
Application: 12/712,323 →
Publication: US 2010/0152279
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
Application: 12/912,061 →
Publication: US 2011/0054008
Rnai-Mediated Inhibition of Ocular Hypertension Targets
Application: 12/967,121 →
Publication: US 2011/0124708
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Patent: 8,173,617 →
Application: 13/084,944 →
Publication: US 2011/0190381
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
Application: 13/362,549 →
Publication: US 2012/0122961
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Patent: 9,040,494 →
Application: 13/429,913 →
Publication: US 2012/0178795
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
Application: 13/682,152 →
Publication: US 2013/0123337
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
Application: 14/180,145 →
Publication: US 2014/0357692
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
Application: 14/615,144 →
Publication: US 2015/0225720
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Patent: 9,550,994 →
Application: 14/692,402 →
Publication: US 2015/0307882
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →
Change of Name Aug 12, 2024
From: ARROWHEAD RESEARCH CORPORATION
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068551/0204 →
Change of Name Aug 12, 2024
From: ARROWHEAD RESEARCH CORPORATION
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068551/0234 →